326 related articles for article (PubMed ID: 30756388)
1. β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.
Du XJ; Zhao WB; Nguyen MN; Lu Q; Kiriazis H
Br J Pharmacol; 2019 Jul; 176(14):2449-2464. PubMed ID: 30756388
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
Zhao WB; Lu Q; Nguyen MN; Su Y; Ziemann M; Wang LN; Kiriazis H; Puthalakath H; Sadoshima J; Hu HY; Du XJ
Br J Pharmacol; 2019 Jul; 176(14):2465-2481. PubMed ID: 30932177
[TBL] [Abstract][Full Text] [Related]
3. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
[TBL] [Abstract][Full Text] [Related]
4. Gal-3 (Galectin-3) and K
She G; Hou MC; Zhang Y; Zhang Y; Wang Y; Wang HF; Lai BC; Zhao WB; Du XJ; Deng XL
Hypertension; 2020 Feb; 75(2):393-404. PubMed ID: 31838908
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
[TBL] [Abstract][Full Text] [Related]
6. β
Calvani M; Bruno G; Dal Monte M; Nassini R; Fontani F; Casini A; Cavallini L; Becatti M; Bianchini F; De Logu F; Forni G; la Marca G; Calorini L; Bagnoli P; Chiarugi P; Pupi A; Azzari C; Geppetti P; Favre C; Filippi L
Br J Pharmacol; 2019 Jul; 176(14):2509-2524. PubMed ID: 30874296
[TBL] [Abstract][Full Text] [Related]
7. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β
Dal Monte M; Calvani M; Cammalleri M; Favre C; Filippi L; Bagnoli P
Br J Pharmacol; 2019 Jul; 176(14):2496-2508. PubMed ID: 30471093
[TBL] [Abstract][Full Text] [Related]
8. Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.
Chia LY; Evans BA; Mukaida S; Bengtsson T; Hutchinson DS; Sato M
Br J Pharmacol; 2019 Jul; 176(14):2433-2448. PubMed ID: 30740664
[TBL] [Abstract][Full Text] [Related]
9. Cardiac β
Arioglu-Inan E; Kayki-Mutlu G; Michel MC
Br J Pharmacol; 2019 Jul; 176(14):2482-2495. PubMed ID: 30801686
[TBL] [Abstract][Full Text] [Related]
10. What makes the α
White CW; da Silva Junior ED; Lim L; Ventura S
Br J Pharmacol; 2019 Jul; 176(14):2358-2365. PubMed ID: 30719698
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
[TBL] [Abstract][Full Text] [Related]
12. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
[TBL] [Abstract][Full Text] [Related]
14. β
Igawa Y; Aizawa N; Michel MC
Br J Pharmacol; 2019 Jul; 176(14):2525-2538. PubMed ID: 30868554
[TBL] [Abstract][Full Text] [Related]
15. Time course and extent of alpha 1-adrenoceptor density changes in rat heart after beta-adrenoceptor blockade.
Steinkraus V; Nose M; Scholz H; Thormählen K
Br J Pharmacol; 1989 Feb; 96(2):441-9. PubMed ID: 2564293
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
[TBL] [Abstract][Full Text] [Related]
17. Adrenoceptors in white, brown, and brite adipocytes.
Evans BA; Merlin J; Bengtsson T; Hutchinson DS
Br J Pharmacol; 2019 Jul; 176(14):2416-2432. PubMed ID: 30801689
[TBL] [Abstract][Full Text] [Related]
18. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
19. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.
Calvier L; Martinez-Martinez E; Miana M; Cachofeiro V; Rousseau E; Sádaba JR; Zannad F; Rossignol P; López-Andrés N
JACC Heart Fail; 2015 Jan; 3(1):59-67. PubMed ID: 25458174
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptors in cardiac disease.
Brodde OE
Pharmacol Ther; 1993 Dec; 60(3):405-30. PubMed ID: 7915424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
